Literature DB >> 14638500

Novispirin G10-induced lung toxicity in a Klebsiella pneumoniae infection model.

Karen H Bartlett1, Paul B McCray, Peter S Thorne.   

Abstract

Mammalian cathelicidins are a class of innate antimicrobial peptides isolated from leukocytes and epithelial cells that aid host defense against bacterial infections. Synthetic analogs of cathelicidins offer the promise of potent broad-spectrum antimicrobial efficacy. We developed a combined lung infection and ex vivo whole-blood assay model to characterize the toxicity and efficacy of synthetic cathelicidin-derived peptides. Male C57BL/6 mice were administered saline or Klebsiella pneumoniae by intratracheal instillation. Five hours later, the Klebsiella-infected mice were instilled with saline, tobramycin (1 mg/kg of body weight or 10 mg/kg), novispirin G10 (0.4 mg/kg), or a combination of tobramycin (1 mg/kg) and G10 (0.4 mg/kg). At 24 h, bronchoalveolar lavage fluid (BAL) was collected for analysis of culturable bacteria and for markers of inflammation and lung toxicity. Blood samples were analyzed for circulating cytokines. Recovery of Klebsiella from the lung, recruitment of neutrophils, and production of interleukin-6 (IL-6) in BAL samples were highly correlated (r=0.68 and 0.84, respectively; P<0.01). Animals treated with G10 or G10 plus tobramycin had increased hemoglobin (P<0.001) and protein (P<0.001) levels compared to those for Klebsiella-infected or tobramycin-alone-treated animals. The levels of circulating IL-6 in mice infected with Klebsiella were 1000- to 10,000-fold higher than in the noninfected controls. The highest levels of IL-6 were measured in mice given G10 alone or in combination with tobramycin. These studies demonstrated that G10 was relatively nontoxic in saline-treated mice but was highly toxic in mice infected with Klebsiella. This finding establishes the importance of investigating candidate antimicrobial agents in an in vivo infection model.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14638500      PMCID: PMC296213          DOI: 10.1128/AAC.47.12.3901-3906.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  26 in total

Review 1.  Inhalation toxicology models of endotoxin- and bioaerosol-induced inflammation.

Authors:  P S Thorne
Journal:  Toxicology       Date:  2000-11-02       Impact factor: 4.221

2.  Activity of abundant antimicrobials of the human airway.

Authors:  S M Travis; B A Conway; J Zabner; J J Smith; N N Anderson; P K Singh; E P Greenberg; M J Welsh
Journal:  Am J Respir Cell Mol Biol       Date:  1999-05       Impact factor: 6.914

3.  Interaction of cationic peptides with bacterial membranes.

Authors:  S Fidai; S W Farmer; R E Hancock
Journal:  Methods Mol Biol       Date:  1997

4.  Cutting edge: cationic antimicrobial peptides block the binding of lipopolysaccharide (LPS) to LPS binding protein.

Authors:  M G Scott; A C Vreugdenhil; W A Buurman; R E Hancock; M R Gold
Journal:  J Immunol       Date:  2000-01-15       Impact factor: 5.422

5.  Early-onset inflammatory responses in vivo to adenoviral vectors in the presence or absence of lipopolysaccharide-induced inflammation.

Authors:  P S Thorne; P B McCray; T S Howe; M A O'Neill
Journal:  Am J Respir Cell Mol Biol       Date:  1999-06       Impact factor: 6.914

6.  In vitro activities of designed antimicrobial peptides against multidrug-resistant cystic fibrosis pathogens.

Authors:  U Schwab; P Gilligan; J Jaynes; D Henke
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

7.  SMAP-29: a potent antibacterial and antifungal peptide from sheep leukocytes.

Authors:  B Skerlavaj; M Benincasa; A Risso; M Zanetti; R Gennaro
Journal:  FEBS Lett       Date:  1999-12-10       Impact factor: 4.124

8.  Bactericidal activity of mammalian cathelicidin-derived peptides.

Authors:  S M Travis; N N Anderson; W R Forsyth; C Espiritu; B D Conway; E P Greenberg; P B McCray; R I Lehrer; M J Welsh; B F Tack
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

9.  Affinities of different proteins and peptides for lipopolysaccharide as determined by biosensor technology.

Authors:  C J de Haas; P J Haas; K P van Kessel; J A van Strijp
Journal:  Biochem Biophys Res Commun       Date:  1998-11-18       Impact factor: 3.575

10.  Evaluation of antimicrobial and lipopolysaccharide-neutralizing effects of a synthetic CAP18 fragment against Pseudomonas aeruginosa in a mouse model.

Authors:  T Sawa; K Kurahashi; M Ohara; M A Gropper; V Doshi; J W Larrick; J P Wiener-Kronish
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

View more
  6 in total

1.  Pegylation of antimicrobial peptides maintains the active peptide conformation, model membrane interactions, and antimicrobial activity while improving lung tissue biocompatibility following airway delivery.

Authors:  Christopher J Morris; Konrad Beck; Marc A Fox; David Ulaeto; Graeme C Clark; Mark Gumbleton
Journal:  Antimicrob Agents Chemother       Date:  2012-03-19       Impact factor: 5.191

2.  Effects of intratracheal administration of novispirin G10 on a rat model of mucoid Pseudomonas aeruginosa lung infection.

Authors:  Zhijun Song; Hong Wu; Per Mygind; Dora Raventos; Carsten Sonksen; Hans-Henrik Kristensen; Niels Høiby
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

3.  Predatory Bacteria Attenuate Klebsiella pneumoniae Burden in Rat Lungs.

Authors:  Kenneth Shatzkes; Eric Singleton; Chi Tang; Michael Zuena; Sean Shukla; Shilpi Gupta; Sonal Dharani; Onoyom Onyile; Joseph Rinaggio; Nancy D Connell; Daniel E Kadouri
Journal:  MBio       Date:  2016-11-08       Impact factor: 7.867

4.  Characterization of Host Responses during Pseudomonas aeruginosa Acute Infection in the Lungs and Blood and after Treatment with the Synthetic Immunomodulatory Peptide IDR-1002.

Authors:  Kelli Wuerth; Amy H Y Lee; Reza Falsafi; Erin E Gill; Robert E W Hancock
Journal:  Infect Immun       Date:  2018-12-19       Impact factor: 3.441

5.  Examining the safety of respiratory and intravenous inoculation of Bdellovibrio bacteriovorus and Micavibrio aeruginosavorus in a mouse model.

Authors:  Kenneth Shatzkes; Richard Chae; Chi Tang; Gregory C Ramirez; Somdatta Mukherjee; Liana Tsenova; Nancy D Connell; Daniel E Kadouri
Journal:  Sci Rep       Date:  2015-08-07       Impact factor: 4.379

6.  Synthetic host defense peptide IDR-1002 reduces inflammation in Pseudomonas aeruginosa lung infection.

Authors:  Kelli C Wuerth; Reza Falsafi; Robert E W Hancock
Journal:  PLoS One       Date:  2017-11-06       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.